![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1424325
¼¼°è ´ç´¢º´ °ü¸® ±â±â ½ÃÀå : Á¦Ç° À¯Çüº°, ÀûÀÀÁõº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°Diabetes Monitoring Devices Market, By Product Type, By Indication, By End User, By Geography |
´ç´¢º´ °ü¸® ÀåÄ¡ ½ÃÀå ±Ô¸ð´Â 2023³â 109¾ï ´Þ·¯·Î Æò°¡µÇ¾ú°í 2030³â 189¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 8.2%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.
º¸°í ´ë»ó ¹üÀ§ | º¸°í¼ ¼¼ºÎÁ¤º¸ | ||
---|---|---|---|
±âÁسâ | 2022³â | 2023/2024³â ½ÃÀå ±Ô¸ð | 109¾ï ´Þ·¯ |
½ÇÀû µ¥ÀÌÅÍ | 2018³â-2021³â | ¿¹Ãø ±â°£ | 2023-2030 |
¿¹Ãø±â°£ 2023³â/2024³â-2030³â/2031³â º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR): | 8.20% | 2030/2031³â °¡Ä¡ ¿¹Ãø | 189¾ï ´Þ·¯ |
Ç÷´çÄ¡ ¸ð´ÏÅÍ´Â ´ç´¢º´ ȯÀÚ¿Í ÀÓ»óÀǰ¡ ȯÀÚÀÇ Ç÷´çÄ¡¸¦ °ü¸®Çϰí Á¦¾îÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ÀÌ·¯ÇÑ ÀåºñÀÇ ´ëºÎºÐÀº º´¿ø ÀÌ¿ÜÀÇ Àå¼Ò¿¡¼ ȯÀÚ¿¡°Ô »ç¿ëµË´Ï´Ù. ÀÌ È¯ÀÚµé Áß ´ëºÎºÐÀº ³ëÀÎÀÌ¸ç ¼Õ³¡ÀÌ ºÒÆíÇÏ°í ½Ã·ÂÀÌ ¶³¾îÁý´Ï´Ù. Ç÷´ç ÃøÁ¤±â´Â ÃøÁ¤ Æ÷Æ®¸¦ °¡Áö°í ÀÖÀ¸¸ç, ȯÀÚ°¡ Ç÷¾×À» ¹Ù¸¥ ÀÛÀº ±³Á¤ Å×½ºÆ® ½ºÆ®¸³À» ³Ö°í ºÐ¼®ÇÕ´Ï´Ù. ¼Õ³¡ÀÌ ºÒÆíÇÑ ÀÌ¿ëÀÚ¿¡ ´ëÀÀÇϱ⠶§¹®¿¡ Å×½ºÆ® ½ºÆ®¸³Àº ³Ê¹« ÀÛ¾Æ ÀÌ¿ëÀÚ°¡ ´Ù·ç±â ¾î·Æ´Ù´Â °ÍÀº ÀÖÀ» ¼ö ¾ø½À´Ï´Ù.
Àü ¼¼°èÀûÀ¸·Î ´ç´¢º´ÀÇ À¯º´·üÀÌ ³ô¾ÆÁö°í ÀÖ´Â °ÍÀº ´ç´¢º´ °ü¸® ÀåÄ¡ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ±¹Á¦ ´ç´¢º´ ¿¬ÇÕÀÇ Ãֽе¥ÀÌÅÍ¿¡ µû¸£¸é 2021³â¿¡´Â ¾à 5¾ï 3,700¸¸¸íÀÇ ¼ºÀÎÀÌ ´ç´¢º´À» ¾Î°í ÀÖÀ¸¸ç, 2045³â¿¡´Â 7¾ï 8,300¸¸¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. ´ç´¢º´Àº Àú¡¤Á߼ҵ汹¿¡ ºÒ±ÕÇüÇÑ ¿µÇâÀ» ¹ÌÄ¡°í, ¸Å³â 120¸¸¸í ÀÌ»óÀÌ »ç¸ÁÇϰí ÀÖ½À´Ï´Ù. ¼¼°è ´ç´¢º´ Àα¸ Áõ°¡¿Í °Ç° ÀÇ½Ä Áõ°¡·Î È¿À²ÀûÀÎ Æ÷µµ´ç °ü¸®°ú Áúº´ °ü¸®°¡ Áß¿äÇØÁö°í ÀÖ½À´Ï´Ù.
±×·¯³ª ÀÌ ½ÃÀåÀº ¾î¶² µµÀü¿¡µµ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. °í±Þ Àåºñ¸¦ ¿î¿µÇϰí Ä¡·á °èȹ¿¡ ÅëÇÕÇϱâ À§ÇØ ÀÇ·á Á¾»çÀÚÀÇ Áö¼ÓÀûÀÎ ±³À°¿¡ ¼Ò¿äµÇ´Â ºñ¿ëµµ °¡°Ý »ó½ÂÀÇ ¿øÀÎÀ̵Ǿú½À´Ï´Ù. »óȯ °èȹ¿¡ ÀÇÇÑ Á¤ºÎÀÇ °³ÀÔÀÌ Á¦ÇѵǾî ÀÖ´Â °Íµµ ´ç´¢º´ ȯÀÚÀÇ Àú·ÅÇÑ °¡°ÝÀ» ´õ¿í ¾ïÁ¦Çϰí ÀÖ½À´Ï´Ù. ±â¼úÀº ´ç´¢º´ °ü¸®¿¡ Çõ¸íÀ» °¡Á®¿Ã °ÍÀ¸·Î ±â´ëµÇ°í ÀÖÁö¸¸, ±× ÇýÅÃÀÌ ´ëÁß¿¡°Ô ħÅõÇÏ´Â °ÍÀº °¡°Ý ¼³Á¤ Àå¾Ö°¡ ÇØ°áµÈ °æ¿ì¿¡¸¸ÀÔ´Ï´Ù. ±â¼ú Çõ½ÅÀ» º¸´Ù Àû´çÇÑ °¡°ÝÀ¸·Î ÀÌ¿ëÇÒ ¼ö ÀÖµµ·Ï ÇÏ´Â ´ëüǰÀÌ °³¹ßµÇÁö ¾Ê´Â ÇÑ, °í°¡°¡ °è¼ÓµÇ±â ¶§¹®¿¡ ƯÈ÷ ÈÄ¹ß °³¹ßµµ»óÁö¿ª¿¡¼´Â ½ÃÀåÀÇ È®´ë°¡ Á¦ÇÑµÇ°Ô µË´Ï´Ù.
ÀÌ·¯ÇÑ °úÁ¦¿¡µµ ºÒ±¸ÇÏ°í ½ÃÀå¿¡´Â ¼ºÀå ±âȸ°¡ ¸î °¡Áö ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºíÇϰí ħ½ÀÀûÀÎ ½Å±â¼úÀÇ °³¹ß·Î ´ç´¢º´ °ü¸®ÀÇ º¯È°¡ ±â´ëµË´Ï´Ù. Ãʱ⠿¹·Î´Â ¼Õ°¡¶ôÀ» Â Çʿ䰡 ¾øÀ¸¸ç ÃÖ´ë 14ÀÏ µ¿¾È ÀåÂø °¡´ÉÇÑ Áö¼Ó Æ÷µµ´ç °ü¸® ½Ã½ºÅÛ µîÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÅëÁõµµ ¹ø°Å·Î¿òµµ °ÅÀÇ ¾ø°í, °£Áú¾×À» ÃßÃâÇÏ´Â ÆÐÄ¡Çü ¼¾¼µµ ½ÃÇèÀûÀ¸·Î °³¹ßµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀ» ÇÕ¸®ÀûÀÎ °¡°ÝÀ¸·Î ³Î¸® »ç¿ëÇÒ ¼ö ÀÖ°Ô µÇ¸é Àϰü¼º ¾ø´Â ÀÚü ±â·Ï¿¡¼ °ÅÀÇ Ç×»ó ÀÚµ¿ÈµÈ °ü¸®À¸·Î °ü¸®¸¦ ¸¶À̱׷¹À̼ÇÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·Î ÀÎÇØ ´ç´¢º´ ȯÀÚ´Â Á¤º¸¸¦ ±â¹ÝÀ¸·Î Àû½Ã¿¡ °³ÀÔÇÏ¿© º´¸®ÇÐÀ» ´õ Àß Á¶ÀýÇÒ ¼ö ÀÖ½À´Ï´Ù.
Global diabetes monitoring devices market size is expected to reach US$ 18.90 Bn by 2030, from US$ 10.90 Bn in 2023, exhibiting a compound annual growth rate (CAGR) of 8.2% during the forecast period.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2022 | Market Size in 2023/2024: | US$ 10.90 Bn |
Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
Forecast Period 2023/2024 to 2030/2031 CAGR: | 8.20% | 2030/2031 Value Projection: | US$ 18.90 Bn |
Blood glucose monitors are used by diabetic patients and clinicians to monitor and to help control a patient's blood glucose level. Most of these devices are used by patients outside the hospital setting. Many of these patients are elderly, with limited manual dexterity and impaired vision. Blood glucose monitors have a reading port into which patients place a small calibrated test strip, onto which they have applied blood, for analysis. In order to accommodate users with limited manual dexterity, the test strips cannot be too small by making the strip difficult for the user to handle.
Growing prevalence of diabetes across the globe is a major factor driving the growth of diabetes monitoring devices market. According to the latest data by the International Diabetes Federation, approximately 537 million adults were living with diabetes in 2021 which is projected to rise to 783 million by 2045. Diabetes disproportionately affects lower and middle-income countries and accounts for over 1.2 million deaths each year. With the rising diabetic population worldwide and increasing health awareness, there is greater emphasis on efficient glucose monitoring and management of the disease.
However, the market also faces certain challenges. The costs involved in continuous training of healthcare providers to operate and integrate advanced devices into treatment plans also contribute to higher prices. Limited government intervention through reimbursement schemes further restrains affordability of diabetic patients. While technology holds promise to revolutionize diabetes management, its benefits can only percolate to masses if pricing obstacles are addressed. Unless alternatives are developed to make innovation more affordable and accessible, high prices will continue limiting market expansion especially in less developed regions.
Despite these challenges, the market presents several opportunities for growth. The development of novel wearable and minimally-invasive technologies is expected to transform diabetes monitoring. A few early examples include continuous glucose monitoring systems that do not require finger pricks and can be worn for up to 14 days. Patch-like sensors have also been trialed that extract interstitial fluid with little pain or hassle. If such solutions become widely accessible in an affordable way, they may help shift management from inconsistent self-tracking to near-constant automated oversight. This could help diabetics better control their condition through informed timely interventions.
Global Diabetes Monitoring Devices Market Detailed Segmentation: